Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Tower (TWR) / FY23

Result released23 November 2023·Annolyse analysis published23 April 2026

Combined ratio hit 101.0%; no FY23 dividend after catastrophe year

Large-event claims of NZ$38.2m drove underwriting into loss and operating cash inflow fell to NZ$10.0m, straining solvency and capital return.

Financials / Insurance

TWR revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY23 was $501.4m, versus $214.1m in HY22.

TWR EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
EBITDA margin across covered periods.

TWR operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY23 was $18.2m, versus $25.1m in HY22.

TWR NPAT trajectory

Statutory profit after tax across covered periods.

↗
Loading chart...
HY23 was -$5.1m, versus $2.9m in HY22.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 21 July 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$642.2m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

11.29x

i

Recent market cap compared with trailing earnings.

EPS

0.17

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not meaningful without positive comparable earnings growth.

EV/EBITDA

Not available

i

Not useful for this reporting shape.

P/FCF

Not available

i

Not available for this company right now.

P/B

2.02x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

11.5%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
23 November 2023
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY23 vs FY22

Revenue

$725.2m

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

−$1.2m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$10m

Caveat: metric quality flags apply; use this value with basis context.

Declared dividend per share

—

Caveat: metric quality flags apply; use this value with basis context.

Operating profit

−$11.7m

Caveat: metric quality flags apply; use this value with basis context.

Profit before tax

$7.4m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$64m

-24.3% ↓ vs $84.5m

Total assets

$946.2m

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofTWR FY23·Result released23 November 2023·Annolyse analysis published23 April 2026

What changed

Tower swung into an underwriting loss in FY23 as the combined ratio rose to 101.0% from 90.1%, driven by large-event claims of NZ$38.2m versus NZ$19.0m

Net earned premium grew to NZ$416.3m from NZ$361.1m, but the reported result became a NZ$1.2m loss versus an NZ$18.9m profit, and no FY23 dividend was declared (FY22 included a 4.0 cent final).

Operating cash inflow fell to NZ$10.0m from NZ$59.8m, an 83.3% decline. Pre-lease free cash flow of NZ$7.5m is the weakest in Annolyse's historical baseline for Tower (4-period mean NZ$109.4m, range NZ$56.6m–NZ$142.8m). The disclosed solvency position was materially reduced (23% reported, versus 205% disclosed in FY22), and management explicitly tied the no-dividend decision to large-event impacts on profit and solvency.

What matters

Underwriting crossed into loss, and not only because of catastrophes

A combined ratio of 101.0% means claims and expenses exceeded premium earned before any investment contribution. The large-events ratio rose to 13.4% from 5.3%, but the business-as-usual claims ratio also worsened to 55.5% from 48.9%. This matters because it tests whether targeted rate increases are enough to restore underwriting profitability without help from a benign weather year.

Catastrophes consumed capital and dictated the payout decision. With the solvency position weakened and large-event claims doubling, the board declared no FY23 dividend. Capital adequacy, not earnings ambition, is currently setting payout policy, which is the relevant frame for assessing when distributions can resume.

Cash generation collapsed against the historical baseline. Pre-lease free cash flow of NZ$7.5m versus a 4-period historical mean of NZ$109.4m is classified as unprecedentedly low in the supplied baseline. For a general insurer, this matters because cash is what funds reinsurance, claims settlements, and solvency headroom, so a thin year amplifies pressure heading into the FY24 reinsurance program.

Expectations

No formal FY24 financial target or solvency restoration timeline was supplied

The half-year context shows HY23 reported a NZ$5.1m loss, so the implied second half delivered a small positive NPAT of NZ$3.9m but operating cash flow of -NZ$8.2m; the second half stabilised earnings without repairing cash.

With the FY24 catastrophe budget reset, continued rate increases, and net investment income running NZ$13.1m higher on yields, the recovery thesis is plausible but conditional on a more normal large-events year. The release does not quantify what a sub-100% combined ratio assumes for claims inflation or perils experience, so the path back to underwriting profit and dividend resumption is asserted, not parameterised.

Quality of result

The result is heavily catastrophe-distorted and structurally noisy, so several headline reads should be treated with caution

Net investment income lifted by NZ$13.1m on higher yields and offset some of the underwriting pressure; that benefit is rate-driven rather than underwriting-quality-driven, and would moderate if rates fall. Total revenue at NZ$725.2m versus NZ$438.7m is not a like-for-like underlying movement, given basis-discontinuity caveats in the supplied data and the discontinued-operation overlay tied to disclosed Papua New Guinea and Suva exits; net earned premium growth (NZ$416.3m vs NZ$361.1m) is the cleaner premium read.

The effective tax rate of 68.4% sits well outside Tower's historical range (4-period mean 30.5%, range 28.9%–32.1%, classified as unprecedentedly high in the supplied baseline). That reflects the arithmetic of a small pre-tax profit alongside a NZ$3.6m discontinued-operation loss, so PBT and NPAT growth comparisons to FY22 are not directly meaningful and analytical-calculation values for those growth lines carry basis-discontinuity caveats. The cleanest reads of FY23 quality are the combined ratio, the BAU claims ratio, and operating cash flow, all of which point to a materially weaker year than headline revenue suggests.

Unresolved

Open questions

What does the FY24 reinsurance program look like in retention, cost, and aggregate cover after a catastrophe-heavy year?
How does management quantify the path back to a sub-100% combined ratio, and what claims-inflation assumption underpins the FY24 BAU claims ratio?
What solvency level does the board treat as the threshold for resuming dividends?
Why did the BAU claims ratio rise 660 basis points, and how much of that is inflation versus mix or volume?
How resilient is the Pacific segment's NZ$8.8m result given its own catastrophe exposure and the group's reduced capital buffer?

This briefing cannot assess FY24 catastrophe outcomes, reinsurance pricing changes, or whether the announced rate actions will fully offset underlying claims inflation.

Chat

Ask about TWR FY23

Ask follow-up questions about Tower's FY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about TWR FY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Tower's FY23 result.

What does the FY24 reinsurance program look like in retention, cost, and aggregate cover after a catastrophe-heavy year?Why does "Underwriting crossed into loss, and not only because of catastrophes" matter?How strong was the cash and earnings quality in FY23?What should I watch next for TWR after FY23?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Annual Report (including Financial Statements)

FY23 / financial report↗

Results Announcement

FY23 / results announcement↗

Results Announcement

FY23 / results release↗

Results Presentation

FY23 / results presentation↗

Prior comparable period

Annual Report

FY22 / financial report↗

Interim context

Tower HY23 Financial Statements (including auditor's report)

HY23 / financial report↗

Tower HY23 Media Release

HY23 / media release↗

Tower HY23 Results Announcement

HY23 / results announcement↗

Tower HY23 Results Announcement Presentation

HY23 / results presentation↗

Release context

Tower updates FY23 guidance and large events costs

FY23 / commentary↗

Annual Meeting Address

HY23 / commentary↗

Tower Updates Guidance, Provides Update on Large Events

HY23 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 36.0pp, with a distortion flag in the result.

→

Revenue growth context

Revenue growth was 65.3% for this reporting period.

→

ROE and capital efficiency

ROE was -0.4%, -6.3pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when TWR publishes next

Get the next Tower briefing and related NZX reporting-season updates by email.